Cargando…
Value assessment of artificial intelligence in medical imaging: a scoping review
BACKGROUND: Artificial intelligence (AI) is seen as one of the major disrupting forces in the future healthcare system. However, the assessment of the value of these new technologies is still unclear, and no agreed international health technology assessment-based guideline exists. This study provide...
Autores principales: | Fasterholdt, Iben, Naghavi-Behzad, Mohammad, Rasmussen, Benjamin S. B., Kjølhede, Tue, Skjøth, Mette Maria, Hildebrandt, Malene Grubbe, Kidholm, Kristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620604/ https://www.ncbi.nlm.nih.gov/pubmed/36316665 http://dx.doi.org/10.1186/s12880-022-00918-y |
Ejemplares similares
-
Correction: Value assessment of artificial intelligence in medical imaging: a scoping review
por: Fasterholdt, Iben, et al.
Publicado: (2023) -
Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023) -
Economic evaluations of interventions against viral pandemics: a scoping review
por: Rasmussen, M.K., et al.
Publicado: (2022) -
A qualitative exploration of early assessment of innovative medical technologies
por: Fasterholdt, Iben, et al.
Publicado: (2018) -
Prognostic Value of Dual-Time-Point (18)F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2020)